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The Malaysian velogenic-viscerotropic Newcastle disease virus (NDV) strain 
AF2240 is responsible for high mortality and morbidity. Monoclonal antibodies 
(mAbs) have been known to be useful in the identification of NDV due to their 
binding specificity, their homogeneity and their ability to be produced in 
unlimited quantities. It is, however, very difficult to obtain mAbs which are 
specific to NDV commercially. Therefore, this project is to develop mAbs 
against the local NDV strain AF2240. This velogenic-viscerotropic viral strain is 
a reference strain that has often been used for vaccine development. 
Hybridoma cells were created by fusing NDV-hyperimmunised Balblc 
splenocytes with Sp210-Ag14 (Sp2) myeloma cells using polyethylene glycol 
with the molecular weight of 1450 (PEG 1450). Positive clones were screened by 
ELISA. High titre producing clones were selected from a series of limiting 
dilutions. MAbs from stable hybridomas were further characterised by western 
blot analysis, haemagglutination-inhibition test (HI) and haemolysis-inhibition 
test (HLI). 
Eight hybridoma cell lines producing mAbs against the haemagglutinin- 
neuraminidase (HN) glycoprotein of NDV strain AF2240 were generated. 
Isotyping showed that mAbs 1B9, 2D6 and 9D7 were IgG1, mAbs 1D5, 5A10 
and 5F10 were IgG2a and mAbs 2G3 and 5E10 were IgG3. Kappa (K) light 
chains were found in all mAbs. They can be divided into two groups: (1) mAbs 
lD5, 5A10 and 5E10 which recognised conformational and linearised epitopes 
and (2) mAbs 1B9, 2D6 and 9D7 which recognised only conformational 
epitopes. All mAbs showed positive results in the HI test but not HLI test 
conforming that they were specific to the HN protein and not the fusion (F) 
protein. 
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Virus penyakit sampar ayam atau virus penyakit Newcastle (NDV) strain 
ternpatan AF2240 rnenyebabkan kernatian yang tinggi. Antibodi rnonoklonal 
(mAb) sudah diketahui dengan kegunaannya dalam pengenalian NDV 
berasaskan specifikasi ikatan, keseragaman dan keupayaan dihasilkan dalam 
jurnlah yang banyak. Namun demikian, rnAb susah diperolehi secara komersil. 
Maka, projek ini bertujuan menghasilkan rnAb terhadap NDV ternpatan. Virus 
strain velogenic-viscerotropic ini rnenjadi strain rujukan yang kerap digunakan 
dalam penghasilan vaksin. 
Sel hibridorna telah dihasilkan melalui pergabungan sel limfosit Balblc yang 
telah dipertingkatkan imrnunisasinya terhadap NDV dengan sel milorna SpYO- 
Ag14 (Sp2) menggunakan polietilen gliko dengan berat molekul 1450 (PEG 
1450). Klon positif diasai daripada teknik ELISA. Klon yang menghasilkan titer 
tinggi akan dipilih daripada satu siri pencairan terhad. MAb daripada hibridoma 
yang stabil akan dicirikan secara lanjutan melalui analisis 'western blot', ujian 
penghalangan hemagglutinin (HI) dan ujian penghalangan hemolisis (HLI). 
Lapan rangkaian sel hibridoma yang menghasilkan mAb terhadap NDV strain 
AF2240 glikoprotein hemagglutinin-neuraminidase (HN) telah digenerasikan. 
Pengkelasan antibodi telah menunjukkan mAb 1B9, 2D6 dan 9D7 dari sub-kelas 
IgG1, rnAb 1D5, 5A10 dan 5FlO dari sub-kelas IgG2a dan rnAb 2G3 dan 5E10 
dari sub-kelas IgG3. Semua rnAb mempunyai rantai ringan jenis kappa (K). Ia 
juga boleh dibahagikan kepada dua kumpulan: (1) mAb 1D5, 5A10 dan 5E10 
yang mengenali epitop konformasi and linear serta (2) mAb 1B9, 2D6 dan 9D7 
yang mengenali epitop konformasi sahaja. Semua mAb menunjukkan keputusan 
positif terhadap ujian HI dan sebaliknya untuk ujian HLI bagi mengesahkan mAb 
adalah specifik terhadap protein HN dan bukan protein fusion (F). 
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CHAPTER 1 
INTRODUCTION 
Newcastle disease (ND) is regarded throughout the world as one of the two most 
important diseases of poultry and other birds, the other disease being the highly 
pathogenic avian influenza. Its etiologic agent, the Newcastle disease virus 
(NDV), is a member of the family Paramyxovirihe and has been assigned to the 
genus Avulavirus in the subfamily Paramyxovirinae (Mayo, 2002; Peeters and 
Koch, 2002). Alexander (1989) had grouped NDV into five pathotypes based on 
their pathogenic signs: (1) viscerotropic velogenic NDV which causes 
hemorrhagic lesions in the gut; (2) neurotropic velogenic NDV shows respiratory 
and neurological signs but no gut lesions; (3) mesogenic NDV produces low 
mortality with acute respiratory disease and nervous signs in some birds; (4) 
lentogenic NDV shows mild and in apparent respiratory infections and (5) 
asymptomatic enteric NDV, avirulent viruses that appear to replicate primarily in 
the intestinal tract. Regardless of outbreaks or farms under constant surveillance, 
lack of obvious clinical signs or field experts will require confirmatory diagnosis 
for further identification and characterisation of the virus. 
Diagnosis of ND started from the conventional techniques including virus 
isolation; in vivo estimation of pathogenicity through intracerebral pathogenicity 
index (ICPI) and intravenous pathogenicity index (IVPI) in one day old chicks 
and six weeks old chickens, respectively (Alexander, 1988); in vitro studies on 
the fusion protein cleavage site (Aldous and Alexander, 2001) and serological 
tests like haemagglutination (HA) test and haemagglutination-inhibition (HI) 
test. These conventional methods are perceived as slow, laborious and required 
in vivo techniques. Since NDV has a 15.19 kb single-stranded negative RNA 
genome, reverse transcription-polymerase chain reaction (RT-PCR) was used to 
amplify the specific gene region using universal primers, and pathotype-specific 
primers or nested PCR (Aldous and Alexander, 2001). Real-time PCR that can 
detect minute amount (10 pg) of DNA (Tan et al., 2004) and biopanning with a 
fusion phage that carried specific amino acid sequence to interact with surface 
glycoproteins (Ramanujam et al., 2004) have also been performed. 
Besides molecular-based techniques, monoclonal antibodies (mAbs) were 
intensively used in identification and differentiation of NDV strains [Iorio and 
Bratt, 1983 (Australia-Victoria strain); Nishikawa et al., 1983 (D2& Russell and 
Alexander, 1983 (Ulster 2C); Ishida et al., 1985 (Miyadera and Taka); Abenes et 
al., 1986 (Sato); Erdei e t  al., 1987 (La Sota); Yusoff et  al., 1988 (Beaudette C); 
Jestin et al., 1989 (Ploufragan); Panshin et al., 1999 (Israel)]. MAbs were 
employed to study the antigenic differentiation among strains where single amino 
acid changes at the directed epitope can be detected (Chambers et al., 1988; 
Yusoff et  al., 1989). The mAb era began in 1975 with a report in Nature by 
Kohler and Milstein entitled 'Continuous cultures of fused cells secreting 
antibody of predefined specificity'. It was reported that they could fuse 
immortalized myeloma cells with splenocytes which secreted a specific antibody 
of interest. The cell line that produces such antibodies is termed hybridoma. 
Since then, mAbs have become increasingly valuable in both research and 
therapeutic applications. The usefulness of mAbs can be characterised into three 
main points: their specificity of binding, their homogeneity and their ability to be 
produced in unlimited quantities (Harlow and Lane, 1988). Since the antibodies 
produced are from one specific hybridoma cell, their identical properties make 
them very powerful in their ability to detect any specific epitope. Alexander et al. 
(1997) had allocated over 1500 NDV into different groups based on their ability 
to react with different panels of mAbs. MAbs have also been used to distinguish 
vaccine viruses from epizootic viruses in a given area (Srinivasappa et al., 1986). 
Nevertheless, it is very difficult to obtain mAbs which are specific to NDV 
commercially. Therefore, the objectives of this study are: 
a) to generate a panel of murine n~onoclonal antibodies against NDV strain 
AF2240 and 
b) to characterise the selected hybridoma clones. 
CHAPTER 2 
LITERATURE REVIEW 
Kohler and Milstein (1975) had successfully developed a technique that allows 
the growth of cells secreting antibodies with a defined specificity. In this 
technique the splenocytes isolated from an immunised animal, is fused with 
myeloma cells, a type of tumour cell. These hybrid cells or better known as 
hybridomas can be cultured in vitro. Antibodies secreted from hybridomas are 
known as monoclonal antibodies (mAbs). 
Basic Concepts in Hybridoma Technology 
2.1.1 Somatic Cell Hybridisation 
The techniques of somatic cell fusion used by Kohler and Milstein (1975) to 
generate hybridomas secreting anti-sheep red blood cell with inactivated Sendai 
virus was a breakthrough in the field of cell biology. Cell fusion between 
lymphocytes and myelomas was associated with the presence of Sendai virus 
fusion glycoprotein, making it possible for their membrane to coalesce, 
cytoplasm to intermingle and multinucleated homokaryons and heterokaryons 
were formed (Gordon, 1975). Thus, different viruses with surface glycoproteins 
such as Semliki Forest virus, vesicular stomatitis virus, fowl plaque virus and 
influenza virus (White et al., 1980, 1981) were applied to study cell fusion 
mechanisms. Another breaktitrough was using Epstein-Barr virus (EBV) to fuse 
human peripheral blood lymphocytes with human plasmacytomas to generate 
human mAbs (Roder, 1986). 
The tumour caused by malignantly transformed antibody secreting cells is known 
as myeloma or plasmacytoma. According to Goding (1996), pathologists may 
make a morphological distinction between these terms but they may be regarded 
as biologically identical. Mineral oil or pristane were found to be potent inducers 
of myeloma in Balblc mouse. Myelomas that were isolated using this approach 
were termed mineral oil plasmacytoma (MOPC) (Potter and Boyce, 1962; Potter, 
1972). Myelomas that are used as fusion partners should not produce antibodies 
to avoid production of hybridomas that secrete more than one type of antibody. 
Harlow and Lane (1988) have recommended the following cell lines as gooa 
fusion partners and were successfully being used in the cited articles: FO (Davis 
et al., 1982; Mao and France, 1984); FOX-NY (Lane, 1985); NS1/1-Ag4-1 
(Nishikawa et al., 1983; Russell and Alexander, 1983; Yusoff et al., 1988; 
Llames et al., 2000); Sp210-Ag14 (Iorio and Bratt, 1983; Long et al., 1986; 
Letellier et al., 2001; Fontes et al., 2005) and X63Ag8.653 (Davis et al., 1982; 
Srinivasappa et al., 1986). 
Splenocytes are obtained from the immunised mouse through splenectomy. A 
spleen from an immunised mouse contains approximately 5 x lo7 to 2 x 10' 
splenocytes (Harlow and Lane, 1988). Marusich (1988) reported that 1 x lo5 
splenocytes were sufficient to generate hybridomas. Hybridoma cells are created 
by fusing splenocytes from an imnlunised animal with myeloma cells to enable 
the hybridomas to possess both the antibody secreting properties of the parent 
